MINNEAPOLIS–(BUSINESS WIRE)–Blue Belt Technologies, a medical technology company specializing in robotic solutions for orthopedic surgery, announced the results of a strong commercial performance in 2014, their first full year of commercialization.
“Blue Belt had a strong year and I am very pleased with our results”
In 2014, Blue Belt sold 33 Navio® Surgical Systems in multiple countries. Blue Belt’s customers include major teaching institutions, community hospitals, and a fast-growing market in ambulatory surgery centers. More than 900 partial knee replacements have been performed with five different implant partners and Blue Belt’s proprietary STRIDE™ Unicondylar Knee System. Blue Belt Technologies also received FDA clearance to market and sell a new application for patellofemoral joint replacement surgery, increasing the potential audience for robotic-assisted partial knee replacement procedures. 
“Blue Belt had a strong year and I am very pleased with our results,” said Eric Timko, President and CEO of Blue Belt Technologies. “For our company, 2014 was about execution and growth in our first full-year of commercialization. We accomplished our goals, achieving significant milestones throughout the year, and will be riding tremendous momentum moving into 2015. We will continue to focus on our commercial expansion both in the U.S. and OUS as well as further expanding our application pipeline in both joint reconstruction and sports medicine.”
The Navio system provides robotic assistance for partial knee replacement procedures through proprietary CT-free navigation software and a unique handheld, computer-controlled, bone-shaping tool. The Navio system brings a high degree of implant placement accuracy along with soft-tissue balancing benefits for patients suffering from early to mid-stage osteoarthritis.
Blue Belt Technologies, Inc.
Blue Belt Technologies, Inc. is developing the next generation of “smart” surgical instruments for initial use in orthopedic procedures and then for other surgical specialties, including neurosurgery, spinal and otolaryngology (“ENT”). The Company’s Navio™ System incorporates patented technology to provide precise robotic control to surgeons via an intelligent, handheld, computer-assisted, bone-cutting tool. The Navio System provides the surgeon with a layer of safety and enhanced accuracy while performing bone-shaping tasks through minimally invasive incisions. The Company’s STRIDE™ Unicondylar Knee system provides advanced implant features optimized for use with Navio.
Contacts
Blue Belt Technologies, Inc.
Adam Simone, +1-763-452-4917
asimone@bluebelttech.com
www.BlueBeltTech.com